Glucokinase Antibody (YA2040)

Glucokinase Antibody (YA2040) is a biotin-conjugated non-conjugated IgG antibody, targeting Glucokinase, with a predicted molecular weight of 52 kDa (observed band size: 52 kDa). Glucokinase Antibody (YA2040) can be used for WB experiment in human background.

The related gene encodes a member of the hexokinase family of proteins. Hexokinases phosphorylate glucose to produce glucose-6-phosphate, the first step in most glucose metabolism pathways. In contrast to other forms of hexokinase, The enzyme is not inhibited by its product glucose-6-phosphate but remains active while glucose is abundant. The use of multiple promoters and alternative splicing of The related gene result in distinct protein isoforms that exhibit tissue-specific expression in the pancreas and liver. In the pancreas, The enzyme plays a role in glucose-stimulated insulin secretion, while in the liver, The enzyme is important in glucose uptake and conversion to glycogen. Mutations in The related gene that alter enzyme activity have been associated with multiple types of diabetes and hyperinsulinemic hypoglycemia.

2645

Predicted band size: 52 kDa; Observed band size: 52 kDa

Affinity Purified

Non-conjugated

Unmodified

Signal Transduction

Primary Antibody; Recombinant Rabbit Monoclonal Antibody

Recombinant, Monoclonal

Rabbit

Human

P35557

WB: 1/500-1/1000

WB

Liquid

Supplied in rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.

Stored at -20°C for 1 year. Avoid repeated freeze / thaw cycles.

Shipping with blue ice.

IgG

Endogenous

A synthesized peptide derived from human Glucokinase